Biolase stock forecast.

According to Biolase 's latest financial reports and stock price the company's current number of shares outstanding is 1,179,000. At the end of 2023 the ...

Biolase stock forecast. Things To Know About Biolase stock forecast.

Nov 27, 2023 · BIOLASE Stock Forecast and Price Target. The average price target for BIOLASE's stock set by recognized analysts recently is $21.50, which would result in a potential upside of approximately 1753.45% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $2.50. 31 dic 2019 ... ... forecast period. ... exercisable to 1,800,000 shares of BIOLASE Common Stock, with an exercise price of $10.00 per share of BIOLASE common stock.Stockholders Urged to Vote "FOR" the Reverse Stock Split. FOOTHILL RANCH, Calif., Oct. 27, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today issued a letter to stockholders concerning BIOLASE's upcoming special meeting of stockholders on November 19, 2021. BIOLASE's Board of Directors unanimously ...Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.Web

Read Full Company Summary for BIOL here. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Workhorse Group share forecasts, stock quote and buy / sell signals below. According to present data Workhorse Group's WKHS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the …Biolase shares are trading lower after the company announced the pricing of a $4.5 million underwritten public offering. benzinga.com - May 24 at 10:11 AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants.WebBIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.BIOLASE Probability Of Bankruptcy is currently at 95.66%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability …Jul 26, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The 1-for-100 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 104 million shares to ...

Biolase shares are trading lower after the company announced the pricing of a $4.5 million underwritten public offering. benzinga.com - May 24 at 10:11 AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants.Web

Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.

Biolase Inc Stock Forecast and Price Prognosis Data for 2023. History. Forecast. Data. Market. Q&A. Comments. Buy CRYPTO. Select other stock...BIOLASE Stock Earnings. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release …Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2025 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 1.91%, beckoning investors to consider amplifying their portfolios.BIOLASE Probability Of Bankruptcy is currently at 95.66%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability …Nov 14, 2023 · BIOLASE stock price predictions for 2022 using artificial intelligence. How much will BIOLASE stock be worth in 2022? Target price in 2022. BIOLASE Stock Buy Hold or Sell Recommendation. BIOL Stock. USD 0.54 0.02 3.57%. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BIOLASE is 'Strong Sell'. Macroaxis provides BIOLASE buy-hold-or-sell recommendation only in the context of selected investment horizon and …

While BIOLASE's business continues to show respectable growth, cash burn remains a major issue. Click here to find out why investors should continue to avoid BIOL stock.On November 9, Biolase will be releasing earnings Q3. Analysts expect Biolase will report losses per share of $1.775. Go here to watch Biolase stock price in real-time ahead of earnings. On ...Price Prediction forecast forBIOLASE to October 12, and an in-depth analysis for the week of 8 October to 14 October. Monthly forecasts BIOL for 2023 with target levels, support & resistance insights to make informed investment decisions.BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 ... Listing Qualifications Staff of Nasdaq Determines to Delist BIOLASE's Common Stock from the Nasdaq Capital Market and to Suspend Trading of the Common Stock at the Opening of Business on June 20 2023.Change in Control Agreement, dated August 9, 2023 by and between Biolase, Inc. and Steven Sandor 08-10 Seventh Amendment to Restated Certificate of Incorporation 07-26 - 9 views BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023 07-26 - 6 viewsThe company reported ($5.19) earnings per share (EPS) for the quarter. The firm earned $0.67 million during the quarter. Ideanomics had a negative trailing twelve-month return on equity of 246.84% and a negative net margin of 931.66%.

The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.

Biolase stock price target cut to $11 from $14 at Ascendiant Capital Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore Biolase started at speculative buy with $2 stock price target at …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Read Full Company Summary for BIOL here. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …WebBiolase -20%. TELA Bio -18%. Adaptive Biotechnologies -14%. S&P 500 Health Care ... Goldman Sachs channels Taylor Swift for its 2024 stock market forecast Today, 4:48 PM 3 Comments.Web

27 oct 2021 ... ... stock at this time. If a reverse stock split causes our stock price to exceed $1.00 per share, those institutional investors will be able to ...

In the year ago quarter, BIOLASE had a $3.0 million gain on debt forgiveness from the Paycheck Protection Program loan, which positively impacted net income. Net loss per share for the quarter was $0.91 compared to $0.12 for the second quarter of 2021 (as adjusted for the reverse stock split).Web

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™. The ...Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12. BIOLASE, Inc. to Report Q2, 2022 Results on Aug …Assertio Holdings Inc () Stock Market info Recommendations: Buy or sell Assertio Holdings stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Assertio Holdings share forecasts, stock quote and buy / sell signals below.According to present data Assertio Holdings's ASRT shares and potentially its market environment …31 dic 2019 ... ... forecast period. ... exercisable to 1,800,000 shares of BIOLASE Common Stock, with an exercise price of $10.00 per share of BIOLASE common stock.Stockholders Urged to Vote "FOR" the Reverse Stock Split. FOOTHILL RANCH, Calif., Oct. 27, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today issued a letter to stockholders concerning BIOLASE's upcoming special meeting of stockholders on November 19, 2021. BIOLASE's Board of Directors unanimously ...27 jun 2012 ... Dental laser manufacturer and distributor Biolase has this week announced that there is “no fundamental reason” for the recent decline in its ...Dec 1, 2023 · The Soligenix, Inc stock price fell by -25.53% on the last day (Friday, 1st Dec 2023) from $0.98 to $0.730. During the last trading day the stock fluctuated 25.14% from a day low at $0.711 to a day high of $0.89. The price has been going up and down for this period, and there has been a 80.56% gain for the last 2 weeks. Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2024 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 3.55%, beckoning investors to consider amplifying their portfolios.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.The forecast for beginning of March 511. Maximum value 527, while minimum 467. Averaged NVIDIA stock price for month 501. Price at the end 497, change for March -2.74%. NVIDIA Stock Forecast For Tomorrow, Week, Month. Netflix Stock Forecast 2023, 2024, 2025. NVIDIA stock price predictions for April 2024. The forecast for beginning of …Web

We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is …BIOLASE expects total revenue for the 2021 second quarter to be between $7.5M to $8.5M. Net loss for the first quarter was $6.9M, or $0.06 per share, compared to a net loss of $6M, or $0.19 per ...BIOL was always, in my mind, a long term play - For it's sensible that the dentistry sector will see a boost post C-19. This market dip just has made any pump and dump type of scenarios highly unlikely in the short term for this stock, too. Their dental product seems pretty unique and with vaccinations for covid calming folks down, dentist ...WebInstagram:https://instagram. cell phone insurance companiescharles schwab buys td ameritraderetail reitinvestment management courses online BIOLASE Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.63 - $1.68. A $0.04 range width can provide 2.55% volatility. The weighted average price of this range is at $1.65, which is $0.02 lower than the previous day's weighted average price.Gen Restaurant Group Inc. (Nasdaq: GENK), also known as Gen Korean BBQ, fell 11% to $7.76 and a $250.8 million market cap. In third quarter earnings reported yesterday, the company reported revenue of $45.6 million, missing analyst estimates of $46.6 million. It also said comparable restaurant sales slipped 1.2% and operating … option trading signalstesla buy or sell Read Full Company Summary for BIOL here. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and ...BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022 short term financial goals Find the latest analyst research for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.There is a positive fundamental outlook for the life sciences tools & services (LSTS) sub-industry for the next year. In 2021, adjusted EPS are expected to grow, reversing the subpar growth seen in 2020, assuming a healthier economic environment globally. ... Overall, BIOLASE Inc stock has a Value Grade of NA, Growth Grade of D, …Biolase logo. Biolase. BIOL. $1.67, 1.21%, USA. What is the market capitalization of a company? The market capitalization sometimes referred as Marketcap, ...